HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jin-Cherng Lien Selected Research

Thrombosis (Thrombus)

1/2016A novel thromboxane receptor antagonist, nstpbp5185, inhibits platelet aggregation and thrombus formation in animal models.
4/2011NP-313, 2-acetylamino-3-chloro-1,4-naphthoquinone, a novel antithrombotic agent with dual inhibition of thromboxane A(2) synthesis and calcium entry.
6/2010NP-184[2-(5-methyl-2-furyl) benzimidazole], a novel orally active antithrombotic agent with dual antiplatelet and anticoagulant activities.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jin-Cherng Lien Research Topics

Disease

38Neoplasms (Cancer)
10/2022 - 01/2012
9Mouth Neoplasms (Oral Cancer)
11/2019 - 05/2013
8Leukemia
11/2021 - 01/2012
6Neoplasm Metastasis (Metastasis)
09/2021 - 01/2015
5Glioblastoma (Glioblastoma Multiforme)
10/2022 - 11/2018
5Lung Neoplasms (Lung Cancer)
01/2018 - 05/2015
4Breast Neoplasms (Breast Cancer)
09/2021 - 04/2015
4Melanoma (Melanoma, Malignant)
07/2021 - 01/2012
3Infections
12/2019 - 11/2018
3Inflammation (Inflammations)
01/2018 - 12/2010
3Thrombosis (Thrombus)
01/2016 - 06/2010
2Pancreatic Neoplasms (Pancreatic Cancer)
01/2024 - 01/2023
2Uterine Cervical Neoplasms (Cancer of the Cervix)
12/2020 - 09/2020
2Urinary Bladder Neoplasms (Bladder Cancer)
04/2019 - 11/2014
2Edema (Dropsy)
02/2013 - 12/2010
1Carcinogenesis
01/2023
1Brain Ischemia (Cerebral Ischemia)
09/2022
1Hepatocellular Carcinoma (Hepatoma)
10/2021
1Stomach Neoplasms (Stomach Cancer)
09/2021
1Nasopharyngeal Carcinoma
07/2020
1Necrosis
01/2018
1Neointima
01/2018
1Cardiovascular Diseases (Cardiovascular Disease)
01/2018
1Atherosclerosis
01/2018
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
04/2017
1B-Cell Lymphoma (Lymphoma, B Cell)
04/2017
1Skin Neoplasms (Skin Cancer)
03/2017
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
03/2017
1Prostatic Neoplasms (Prostate Cancer)
11/2016
1Colorectal Neoplasms (Colorectal Cancer)
09/2016
1Pulmonary Embolism
01/2016
1Hemorrhage
01/2016

Drug/Important Bio-Agent (IBA)

11Proteins (Proteins, Gene)FDA Link
11/2021 - 05/2013
7CurcuminIBA
11/2021 - 05/2013
6Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2022 - 01/2012
5tetrandrineIBA
11/2021 - 08/2013
5demethoxycurcuminIBA
11/2021 - 05/2015
4CaspasesIBA
01/2023 - 08/2013
4AntioxidantsIBA
09/2022 - 09/2009
4Reactive Oxygen Species (Oxygen Radicals)IBA
10/2021 - 01/2012
4Antineoplastic Agents (Antineoplastics)IBA
07/2020 - 01/2015
3Antiviral Agents (Antivirals)IBA
12/2019 - 11/2018
3casticinIBA
04/2019 - 03/2016
3Complex MixturesIBA
11/2016 - 01/2015
3Matrix Metalloproteinase 2 (Gelatinase A)IBA
03/2016 - 05/2013
2carbazoleIBA
01/2024 - 01/2023
2Chalcone (Benzalacetophenone)IBA
01/2024 - 01/2023
2Phosphates (Orthophosphate)IBA
11/2021 - 04/2015
22,3,4-tri-O-acetylarabinopyranosyl isothiocyanate (AITC)IBA
09/2021 - 01/2016
2Matrix Metalloproteinases (MMPs)IBA
09/2021 - 01/2015
2allyl isothiocyanateIBA
09/2021 - 01/2016
2Emodin (Archin)IBA
03/2019 - 01/2015
2FlavonoidsIBA
01/2019 - 01/2017
2IsothiocyanatesIBA
11/2018 - 01/2012
2benzyl isothiocyanateIBA
11/2018 - 01/2012
21- benzyl- 2- (5- methyl- 2- furyl)benzimidazoleIBA
01/2018 - 01/2016
2deguelinIBA
01/2018 - 01/2017
2Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
01/2018 - 01/2016
2Thromboxane Receptors (Thromboxane Receptor)IBA
01/2018 - 01/2016
2Anthocyanins (Anthocyanin)IBA
07/2017 - 01/2015
2Cantharidin (Cantharides)IBA
03/2017 - 02/2015
2CytokinesIBA
10/2016 - 02/2013
2Fluorescein (Funduscein)FDA LinkGeneric
04/2011 - 06/2010
1bisdemethoxycurcuminIBA
10/2022
1BDMC-AIBA
10/2022
1IsoflavonesIBA
09/2022
1Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
01/2022
1Eosine Yellowish-(YS) (Eosin)IBA
11/2021
1Dimethyl Sulfoxide (DMSO)FDA LinkGeneric
11/2021
1Hematoxylin (Haematoxylon)IBA
11/2021
1SolutionsIBA
11/2021
1KetonesIBA
11/2021
1DiarylheptanoidsIBA
11/2021
1tryptanthrineIBA
10/2021
1Ouabain (G Strophanthin)IBA
09/2021
1TubulinIBA
07/2021
1Asparaginase (Elspar)FDA Link
05/2021
1GenisteinIBA
05/2021
1maslinic acidIBA
12/2020
1TriterpenesIBA
12/2020
1Gefitinib (Iressa)FDA Link
11/2019
1Prostaglandins AIBA
11/2019
1matrigelIBA
10/2019
1Viral RNAIBA
05/2019
1Cadherins (E-Cadherin)IBA
04/2019
1ErbB Receptors (EGF Receptor)IBA
03/2019
1fisetinIBA
01/2019
1CholesterolIBA
01/2018
1Apolipoproteins E (ApoE)IBA
01/2018
1Thromboxane A2 (A2, Thromboxane)IBA
01/2018
1Interleukin-6 (Interleukin 6)IBA
01/2018
1Prostaglandin H2 Thromboxane A2 ReceptorsIBA
01/2018
1bufalinIBA
04/2017
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
10/2016
1NF-kappa B (NF-kB)IBA
10/2016
1Angiogenesis Inducing Agents (Angiogenesis Factor)IBA
09/2016
1bis(p-chlorophenyl)acetic acid (DDA)IBA
09/2016

Therapy/Procedure

4Therapeutics
07/2020 - 05/2012
2Chinese Traditional Medicine (Traditional Chinese Medicine)
03/2017 - 10/2016
1Aftercare (After-Treatment)
11/2021